Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 9/20 | 0.63 |
| ▸ | CA1 | P00915 | 9/20 | 0.63 |
| ▸ | CA2 | P00918 | 9/20 | 0.63 |
| ▸ | CA4 | P22748 | 3/20 | 0.63 |
| ▸ | CA5A | P35218 | 3/20 | 0.63 |
| ▸ | CA7 | P43166 | 3/20 | 0.63 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.63 |
| ▸ | CA9 | Q16790 | 6/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | PRKCA | P17252 | 1/20 | 0.55 |
| ▸ | AKT1 | P31749 | 1/20 | 0.55 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | HPGD | P15428 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.50 |
| ▸ | PARP1 | P09874 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8678884 | 1.00 | CA12 (0.63) | CA12CA1CA2CA4CA5A | |
| SCHEMBL18927631 | 1.00 | CA12 (0.63) | CA12CA1CA2CA4CA5A | |
| SCHEMBL15422483 | 0.92 | CA12 (0.72) | CA12CA1CA2CA4CA5A | |
| SCHEMBL15653572 | 0.92 | CA12 (0.72) | CA12CA1CA2CA4CA5A | |
| SCHEMBL9887787 | 0.92 | CA12 (0.72) | CA12CA1CA2CA4CA5A | |
| SCHEMBL23642758 | 0.92 | CA12 (0.72) | CA12CA1CA2CA4CA5A | |
| SCHEMBL14478515 | 0.92 | CA12 (0.72) | CA12CA1CA2CA4CA5A | |
| SCHEMBL1170779 | 0.92 | CA12 (0.72) | CA12CA1CA2CA4CA5A | |
| SCHEMBL22927973 | 0.92 | CA12 (0.72) | CA12CA1CA2CA4CA5A | |
| SCHEMBL4365300 | 0.92 | CA12 (0.72) | CA12CA1CA2CA4CA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10647737-B2 | Sulfated-glycolipids as adjuvants for vaccines | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2020-05-12 | — | — | US | disclosed |
| US-20170158728-A1 | SULFATED-GLYCOLIPIDS AS ADJUVANTS FOR VACCINES | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2017-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10647737-B2 | Sulfated-glycolipids as adjuvants for vaccines | DEGS1, SGMS1, CD4 | CA12 2565/4885CA1 1075/4885CA2 1746/4885 |
| US-20170158728-A1 | SULFATED-GLYCOLIPIDS AS ADJUVANTS FOR VACCINES | DEGS1, SGMS1, CD4 | CA12 2565/4885CA1 1075/4885CA2 1746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.